Novartis AG (NYSE:NVS) slightly down -0.63% during the previous trading session as the firm held price to earnings ratio of 25.40. Novartis AG signs a licensing contract with Sunovion Pharmaceuticals for the US commercial rights to its three treatments for chronic obstructive pulmonary disease; terms not disclosed (NVS).
Novartis reportedthat it has signed a licensing contract with Sunovion Pharmaceuticals Inc. (Sunovion) for the US commercial rights to its three treatments for chronic obstructive pulmonary disease (:COPD), UtibronNeohaler (indacaterol/glycopyrrolate) inhalation powder, SeebriNeohaler (glycopyrrolate) inhalation powder, and ArcaptaNeohaler (indacaterol) inhalation powder.
Can investors take a chance on buying NVS this week? Find Facts Here
Stocks of Nordic American Tankers Limited (NYSE:NAT) appeared in active trade move, surged 0.12% to trade at $8.58 in last session with shares volume of 1.73 Million. Nordic American Tanker issues a letter to shareholders; 4Q16 cash results are expected to be about $20k per ship per day (NAT).
The 4Q16 cash results are expected to be about $20,000 per ship per day. The NAT fleet is increasing and our 30 Suezmax tanker is slated to be delivered to us mid-Feb 2017. It has already obtained employment for her maiden voyage. Three more newbuildings will increase the fleet with further 10%, impacting dividend and earnings capacity correspondingly.As previously communicated, the 4Q16 is turning out well. Cash break even below $11,000 per ship per day gives an ‘excellent basis’ for solid cash surpluses.
Will Nordic American Tankers Limited retains its glamour following this report? Find Facts Here
Accuray Incorporated (NASDAQ:ARAY) increasing 2.15% to $4.75 with traded session volume was 1.27 Million. Accuray Incorporated (ARAY) has signed an contract with Hong Kong Sanatorium & Hospital for the acquisition of three RadixactTM Systems that will provide clinicians and their patients with access to the newest advanced radiation therapy.
Of the three Radixact Systems, two will replace existing TomoTherapy Systems and one will be installed in a new bunker. The contract also includes an upgrade of HKSH’s existing CyberKnife M6 System to include the latest features for motion management and treatment efficiency, and was entered into backlog during Accuray’s second fiscal quarter which ends December 31, 2016. As concerns of stock price volatility, it was 4.70% for a week and 3.93% for a month.
Can Accuray Incorporated becomes the newest Buy stock following this news? Read Full Report Here